Deliang Fu
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
- Oncology 70
- Pancreatic and Hepatic Oncology Research 58
-
- Cancer Genomics and Diagnostics 9
- Co-authors
- Chen Jin (41 shared papers)Feng Yang (35 shared papers)Di Yang (17 shared papers)Quanxing Ni (13 shared papers)Yongjian Jiang (17 shared papers)Ji Li (17 shared papers)Jin Chen (6 shared papers)Yishen Mao (10 shared papers)
- Journals
- World Journal of Gastroenterology (6 papers)Annals of Surgical Oncology (3 papers)Oncotarget (3 papers)Signal Transduction and Targeted Therapy (2 papers)International Journal of Oncology (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Deliang Fu
108 papers receiving 3.0k citations
Deliang Fu's Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 1.3k
- Cancer Research 576
- Biomaterials 387
- Immunology 282
- Molecular Biology 930
Countries citing papers authored by Deliang Fu
This map shows the geographic impact of Deliang Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deliang Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deliang Fu more than expected).
Fields of papers citing papers by Deliang Fu
This network shows the impact of papers produced by Deliang Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deliang Fu. The network helps show where Deliang Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Deliang Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives Hit paper breakdown → | 2021 | 258 |
| 2 | 2021 | 209 | |
| 3 | 2011 | 163 | |
| 4 | 2021 | 157 | |
| 5 | 2011 | 147 | |
| 6 | 2009 | 136 | |
| 7 | 2012 | 108 | |
| 8 | 2020 | 98 | |
| 9 | 2014 | 94 | |
| 10 | 2009 | 57 | |
| 11 | 2009 | 52 | |
| 12 | 2014 | 52 | |
| 13 | 2013 | 50 | |
| 14 | 2019 | 48 | |
| 15 | 2016 | 45 | |
| 16 | 2008 | 41 | |
| 17 | 2022 | 41 | |
| 18 | 2013 | 40 | |
| 19 | 2020 | 40 | |
| 20 | 2023 | 37 |
About Deliang Fu
Deliang Fu is a scholar working on Oncology, Cancer Research, Surgery, Epidemiology and Molecular Biology, having authored 116 papers that have together received 3.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (58 papers), Neuroendocrine Tumor Research Advances (14 papers), Pancreatitis Pathology and Treatment (13 papers), Cancer Genomics and Diagnostics (9 papers), Nanoparticle-Based Drug Delivery (7 papers), Renal cell carcinoma treatment (7 papers), Epigenetics and DNA Methylation (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (576 citations), Biomaterials (387 citations), Immunology (282 citations) and Molecular Biology (930 citations). Deliang Fu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Chen Jin, Feng Yang, Di Yang, Quanxing Ni, Yongjian Jiang, Ji Li, Jin Chen, Yishen Mao, Zhibo Xie and Caifeng Zou. Their work appears in journals such as World Journal of Gastroenterology, Annals of Surgical Oncology, Oncotarget, Signal Transduction and Targeted Therapy and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.